Cargando…
Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders
Uncontrolled inflammation is considered the pathophysiological basis of many prevalent metabolic disorders, such as nonalcoholic fatty liver disease, diabetes, obesity, and neurodegenerative diseases. The inflammatory response is a self-limiting process that produces a superfamily of chemical mediat...
Autores principales: | Han, Yong-Hyun, Lee, Kyeongjin, Saha, Abhirup, Han, Juhyeong, Choi, Haena, Noh, Minsoo, Lee, Yun-Hee, Lee, Mi-Ock |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411019/ https://www.ncbi.nlm.nih.gov/pubmed/34162770 http://dx.doi.org/10.4062/biomolther.2021.094 |
Ejemplares similares
-
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
por: Salazar, Juan, et al.
Publicado: (2022) -
Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases
por: Tang, Shi, et al.
Publicado: (2018) -
Polyploidization of Hepatocytes: Insights into the Pathogenesis of Liver Diseases
por: Kim, Ju-Yeon, et al.
Publicado: (2022) -
Anti-Inflammatory Effect of Specialized Proresolving Lipid Mediators on Mesenchymal Stem Cells: An In Vitro Study
por: AlZahrani, Shahd, et al.
Publicado: (2022) -
Therapeutic Applicability of Anti-Inflammatory and Proresolving Polyunsaturated Fatty Acid-Derived Lipid Mediators
por: Bannenberg, Gerard L.
Publicado: (2010)